Maxar’s Q3 revealed a net loss of $432.5-million on a top line of $508.2 million, in part due to drag from the company’s GEO Communications segment which was down 31 per cent compared to last year’s Q3.
The stock has also been the victim of a short-selling campaign by Spruce Point Capital Management who intimated that the company’s cash flow problems were bringing solvency issues to the fore.
But both the GEO Comm and leveraging issues aren’t so significant, says Tse, who sees positive catalysts around the corner for Maxar. On the one hand, the company is performing well in segments other than GEO, says Tse, notably, Space Systems which was up 13 per cent year-over-year in the third quarter. On the leverage issue, Tse says Maxar has opportunities coming up to de-risk its balance sheet, with some of its options being the potential sale of its GEO Comm business, real estate divestitures, the securitization of Orbital receivables, cutting into the company’s dividend and dealing with operating efficiencies.
“The reality remains this: MAXR continues to be a 2019 story with most of the meaningful catalysts to re-rate the valuation not surfacing until next year,” says Tse. “And while the Q3 miss adds some doubt to that line of thinking, it’s not enough to have us changing our investment thesis based on a 3.5x P/E (after our estimate revisions) and a ~7.5 per cent dividend yield.”
With his revised estimates, Tse now reiterates his “Outperform” rating with a lowered price target of $45.00 (was $60.00), implying a 12-month projected return of 209 per cent at the time of publication.
Following the company's most recent results, RBC Dominion Securities analyst James McGarragle is feeling more bullish about Air Canada (Air… [Read More]
Docebo (Docebo Stock Quote, Chart, News, Analysts, Financials TSX:DCBO) is under scrutiny following its Q1 2025 earnings report. Despite reporting… [Read More]
Haywood Capital Markets analyst Neal Gilmer says Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) is staying… [Read More]
Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:GUD) is continuing to build momentum, according to Stifel Nicolaus… [Read More]
Roth Capital Partners has raised its price target on Groupon (Groupon Inc Stock Quote, Chart, News, Analysts, Financials NASDAQ:GRPN) to… [Read More]
Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) delivered a strong start to fiscal 2025, beating high-end… [Read More]